These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38443090)

  • 1. Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?
    Duarte C; Ferreira RJO; Welsing PMJ; Jacobs JWG; Gossec L; Machado PM; van der Heijde D; da Silva JAP
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38443090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients.
    Ferreira RJO; Welsing PMJ; Jacobs JWG; Gossec L; Ndosi M; Machado PM; van der Heijde D; Da Silva JAP
    Ann Rheum Dis; 2021 Mar; 80(3):293-303. PubMed ID: 33023964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
    Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
    Studenic P; Felson D; de Wit M; Alasti F; Stamm TA; Smolen JS; Aletaha D
    Ann Rheum Dis; 2020 Apr; 79(4):445-452. PubMed ID: 32024651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision.
    Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
    Ann Rheum Dis; 2023 Jan; 82(1):74-80. PubMed ID: 36280238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.
    Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
    Arthritis Rheumatol; 2023 Jan; 75(1):15-22. PubMed ID: 36274193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
    Rintelen B; Sautner J; Haindl P; Mai H; Brezinschek HP; Leeb BF
    J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME; Hsia E; Aletaha D
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of remission definition on healthcare cost savings estimates for patients with rheumatoid arthritis treated with biologic therapies.
    Barnabe C; Thanh NX; Ohinmaa A; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1600-6. PubMed ID: 25028381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y; Kondo H; Takeuchi T
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and risk of adopting PGA ≤ 2 as a remission criteria of Boolean in clinical practice in patient with rheumatoid arthritis.
    Yoshii I; Chijiwa T; Sawada N
    Sci Rep; 2022 Feb; 12(1):2978. PubMed ID: 35194126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of patient global assessment in the definition of remission as a predictor of long-term radiographic damage in patients with rheumatoid arthritis: protocol for an individual patient data meta-analysis.
    Ferreira RJO; Welsing PMJ; Gossec L; Jacobs JWG; Machado PM; Ndosi M; van der Heijde D; da Silva JAP
    Acta Reumatol Port; 2018; 43(1):52-60. PubMed ID: 29602164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis.
    Messelink MA; den Broeder AA; Marinelli FE; Michgels E; Verschueren P; Aletaha D; Tekstra J; Welsing PMJ
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37116986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis.
    Inanc N; Yilmaz-Oner S; Can M; Sokka T; Direskeneli H
    J Rheumatol; 2014 Sep; 41(9):1755-60. PubMed ID: 25086073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis.
    Carvalho PD; Ferreira RJO; Landewé R; Vega-Morales D; Salomon-Escoto K; Veale DJ; Chopra A; da Silva JAP; Machado PM
    J Rheumatol; 2020 Jan; 47(1):20-27. PubMed ID: 31043552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study.
    Suardi I; Posio C; Luconi E; Boracchi P; Caporali R; Ingegnoli F
    Rheumatol Int; 2023 Oct; 43(10):1885-1895. PubMed ID: 37454308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.
    Shidara K; Nakajima A; Inoue E; Hoshi D; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
    J Rheumatol; 2017 Feb; 44(2):147-153. PubMed ID: 27909083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
    Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
    Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.